Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2013, Vol. 18 ›› Issue (11): 1266-1269.

Previous Articles     Next Articles

Determination of glimepiride and its active metabolite in human plasma by HPLC-MS/MS

LI Ting1,2, NAN Feng1, CHEN Zhi-hui1, YU Qin1, XIANG Jin1, QING Yong-ping1, XIE Kun1, LIANG Mao-zhi1, CHAO Ruo-bing2   

  1. 1Department of Clinical Pharmacology,West China Hospital,Sichuan Uniwersity;
    2Department of Pharmaceutical Analysis,West China School of Pharmacy,Sichuan University,Chengdu 610041, Sichuan ,China
  • Received:2012-11-28 Revised:2013-07-09 Online:2013-11-26 Published:2013-11-22

Abstract: AIM: To develop a sensitive liquid chromatography tandem mass spectrometry(HPLC-MS/MS)method for analyzing glimepiride(G)and its active metabolite hydroxyl-glimepiride(M1)in human plasma.METHODS: G and M1 were extracted from plasma samples by ethyl acetate after acidification,with gliclazide (IS) serving as an internal standard. The analytes went through the column of Phenomenex Gemini C18 (50 mm× 3.0 mm,5 μm) with mobile phase methanol-water-formic acid (80∶20∶0.1) and were analyzed under the multiple reaction monitoring mode using the eletrospray ionization (ESI) technique. The ion pairs being detected were( m/z) 491.4→352.4,507.4→352.4,324.4→127.2,respectively.RESULTS: The standard curves of G and M1 were linear in the range 1.25-400 ng/mL and 0.313-100 ng/mL,with a low limit of quantification of 1.25 and 0.313 ng/mL.The intra and inter day RSD were below 10%,with recovery rates ranging from 96.4% to 102.5%.CONCLUSION: The method is simple, rapid, sensitive, and suitable for the determination of glimepiride and its metabolite in human plasma.

Key words: HPLC-MS/MS, Glimepiride, Hydroxyl-glimepiride, Plasma concentration

CLC Number: